Vitaspring Biomedical (VSBC) Income towards Parent Company (2017 - 2026)
Vitaspring Biomedical (VSBC) recorded Income towards Parent Company of -$155,817 in fiscal Q2 2027 (quarter ended Jul 31, 2026), compared with -$110,845 a year earlier.
Vitaspring Biomedical (VSBC) Income towards Parent Company (2017 - 2026) Analysis & Trends
On a TTM basis, Vitaspring Biomedical's Income towards Parent Company came in at -$455,643 as of Jul 31, 2026; for FY2026 (ended Jan 31, 2026), it came in at -$415,368.
- Across earlier fiscal years, Income towards Parent Company came in at -$774,922 in FY2025, -$1.12 million in FY2024, -$4.16 million in FY2023 and $909,560 in FY2022.
- The fiscal Q2 2027 figure is the lowest quarterly Income towards Parent Company since fiscal Q3 2025.
- Per Business Quant, the preceding three fiscal quarters came in at -$75,844 (Q1 2027), -$81,464 (Q4 2026) and -$142,518 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -155,817.00 |
| Apr 30, 2026 | -75,844.00 |
| Jan 31, 2026 | -81,464.00 |
| Oct 31, 2025 | -142,518.00 |
| Jul 31, 2025 | -110,845.00 |
| Apr 30, 2025 | -80,541.00 |
| Jan 31, 2025 | -143,137.00 |
| Oct 31, 2024 | -196,292.00 |
| Jul 31, 2024 | -218,662.00 |
| Apr 30, 2024 | -216,831.00 |
| Jan 31, 2024 | -225,398.00 |
| Oct 31, 2023 | -234,980.00 |
| Jul 31, 2023 | -353,583.00 |
| Apr 30, 2023 | -304,601.00 |
| Jan 31, 2023 | -4.16 Mn |
| Oct 31, 2022 | -138,281.00 |
| Jul 31, 2022 | -144,135.00 |
| Apr 30, 2022 | 276,656.00 |
| Jan 31, 2022 | 1.23 Mn |
| Oct 31, 2021 | -137,453.00 |
Vitaspring Biomedical Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=VSBC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();